Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oral Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982706/
https://www.ncbi.nlm.nih.gov/pubmed/35392378
http://dx.doi.org/10.3389/froh.2022.893486
_version_ 1784681856466157568
collection PubMed
description
format Online
Article
Text
id pubmed-8982706
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89827062022-04-06 Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings Front Oral Health Oral Health Frontiers Media S.A. 2022-03-22 /pmc/articles/PMC8982706/ /pubmed/35392378 http://dx.doi.org/10.3389/froh.2022.893486 Text en Copyright © 2022 Frontiers Editorial Office. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oral Health
Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
title Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
title_full Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
title_fullStr Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
title_full_unstemmed Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
title_short Retraction: Tumor Microenvironment in Oral Cancer Following Neoadjuvant Pembrolizumab: Preliminary Analysis of the Histopathologic Findings
title_sort retraction: tumor microenvironment in oral cancer following neoadjuvant pembrolizumab: preliminary analysis of the histopathologic findings
topic Oral Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8982706/
https://www.ncbi.nlm.nih.gov/pubmed/35392378
http://dx.doi.org/10.3389/froh.2022.893486
work_keys_str_mv AT retractiontumormicroenvironmentinoralcancerfollowingneoadjuvantpembrolizumabpreliminaryanalysisofthehistopathologicfindings

Ejemplares similares